Navigation Links
Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas

MOUNTAIN VIEW, Calif., Dec. 11 /PRNewswire/ -- Based on its recent analysis of the heart-health supplements market, Frost & Sullivan recognizes SourceOne Global Partners with the 2008 United States Frost & Sullivan Product Innovation Award for methodically readying Cholesstrinol(TM) (a platform for its multiple proprietary heart healthy combinations) products and formulas for the marketplace. From establishing conclusive scientific evidence of its benefits to developing a specific and targeted media awareness campaign, SourceOne has displayed a distinguished understanding of the competitive factors in the nutritional ingredient marketplace.


SourceOne Global Partners has gleaned detailed scientific data into an easy-to-understand package for consumers, thereby reducing, if not eliminating, customers' research efforts. These combinations of formulas have been branded Cholesstrinol(TM), a widely accessed platform that provides numerous customized solutions for consumers with specific cardiovascular concerns.

Cholesstrinol(TM) includes exclusive formulas taken directly from the proprietary and synergistic ingredients, PMF-source(TM) Citrus Flavonoids and TocoSource(R) Palm Tocotrienols. The Cholesstrinol(TM) family of formulae also includes the potent combinations of OmegaChoice(TM) Concentrated Omega-3 Essential Fatty Acids (EFAs), CoQsource(R) Bio-Enhanced Coenzyme Q10, and SterolSource(R) Phytosterols. These are some of the most comprehensive, natural-source, clinically proven 'heart synergy' formulas available.

"Every product under the Cholesstrinol umbrella is supported by a strong platform of clinical evidence demonstrating conclusive ability to deliver a desirable range of heart-healthy benefits," says Frost & Sullivan Research Manager Vivek Tapuriah. "These attributes may include significantly improving healthy cholesterol and triglyceride levels, providing powerful antioxidant effects, promoting the body's natural anti-inflammatory response, and supporting healthy blood pressure and glucose levels."

The benefits of the ingredients in the Cholesstrinol(TM) family have been validated in numerous clinical studies. These studies have substantiated that Cholesstrinol(TM), which combines TocoSource and PMFsource, reduces total cholesterol levels by an average of 25 percent, total low-density lipoprotein (LDL) cholesterol by an average of 23 percent, and total triglycerides by an average of 28 percent, with no adverse effects on the subjects. In the current research-driven supplement industry, these results are expected to go a long way in establishing Cholesstrinol(TM)'s efficacy.

Meanwhile, SourceOne has proactively formed exclusive alliances with global leaders in the areas of scientific research, product development, and innovative patented technologies. Recent examples of these endeavors include collaborations with Vesifact AG, Baar, Switzerland; Twin Rivers Technologies (TRT), Quincy, Massachusetts; and Nutri Pharmaceuticals Research, Inc. (NPRI), Las Vegas, NV.

"The synergies created by these partnerships are directly and immediately applicable to SourceOne ingredients and formulas in various forms and concentrations," notes Tapuriah. "The many benefits obtained from these innovations and the IP technology exchange within the SourceOne 'global partner' network will resonate with its client partners and ultimately, the medical community and consumers focused on health and wellness."

Further, SourceOne has ensured that consumers are well aware of its Cholesstrinol(TM) brand. The company achieved this by implementing the Cholesstrinol(TM) marketing campaign and consumer education program, which promotes Cholesstrinol(TM)'s products and formula benefits across the United States using radio, print, and television media.

"The campaign is estimated to have reached approximately 35 million potential consumers across the United States already, using targeted print journals, radio health stations, and television health and news shows," observes Tapuriah. "This targeted media blitz is expected to have greatly increased the visibility of the Cholesstrinol(TM) brand."

Each year, Frost & Sullivan presents this award to the company that has best demonstrated the ability to develop and/or advance products with more innovative capabilities than competing vendors and products. This Award recognizes the company's successful adoption of new or existing technology that has become a part of its well-designed product family. Such innovation is expected to significantly contribute to the industry in terms of product performance and degree/rate of technical change.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About SourceOne Global Partners

SourceOne Global Partners, headquartered in Chicago, IL, is a leading supplier of innovative, science-based, branded ingredients and proprietary formulas to the nutritional supplement, functional food & beverage, cosmetic, and animal nutrition markets. SourceOne has assembled an impressive and enviable portfolio of complementary condition-specific ingredients that address the most pressing health concerns, including heart health, Type II diabetes, cognitive function, diet and energy, and general wellness.

SourceOne is recognized as a leader in delivering the best science nature has to offer through health solutions like the award-winning Cholesstrinol(TM) Family of Heart Healthy Formulas, OmegaChoice(TM) Concentrated Omega-3 Essential Fatty Acids (EFAs), CoQsource(R) Bio-Enhanced Coenzyme Q10, and SterolSource(R) Phytosterols. The SourceOne product line continues to expand and also includes tocotrienols and tocopherols, palm carotenoids, citrus flavonoids, tongkat ali, green tea, resveratrol, chondroitin, and more.

Building on a tradition of leadership and responsibility in this industry, SourceOne is committed to the highest levels of customer service by providing the newest technologies and highest-quality ingredients that are backed by an experienced technical staff, innovative marketing solutions, and detailed scientific support.

We have assembled an outstanding team of seasoned professionals who are leaders in marketing, technical support, science, business development, and sales in the global nutritional ingredient business marketplace. By cultivating current partnerships and developing new strategic alliances with leading research, product development, and manufacturing companies worldwide, SourceOne is your partner in reaching and expanding your market potential.

For additional information on SourceOne, visit, email to, or call 1-800-755-4996.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership(TM) empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit

     Jake Wengroff

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Excellence in Supply Chain and Manufacturing Recognized at Frost & Sullivans India Manufacturing Excellence Awards 2008
2. Frost & Sullivan Recognises Best-in-Class Innovators
3. Ansell Healthcare Europe Lands 2008 Frost & Sullivan Customer Service Leadership Award for its Ansell Guardian(SM) Safety Program
4. Frost & Sullivan Lauds StatCom for Its Hospital Operations System
5. Gencor Pacific Group Picks Up Frost & Sullivan Global Appetite Suppressant and Satiety Ingredients Product Innovation of the Year Award
6. Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year
7. Healthcare Pioneer Dr. Ralph Snyderman to Receive Frost & Sullivans Lifetime Achievement Award
8. Frost & Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards
9. Frost & Sullivan Recognizes Lifeblood Medical for Its Innovation in Organ Preservation and Development of the Lifor(R) Solution
10. Frost & Sullivan Acknowledges Syntec Optics Unwavering Focus on Innovation and Strategies to Improve Profitability
11. Frost & Sullivan Awards Infor-Med for its Electronic Medical Record Technology
Post Your Comments:
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
(Date:11/26/2015)... Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... On November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction ... , “We wake up every day excited to rebuild lives and it’s an honor ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/26/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact ... and reliability. , The new Q-Suite 6 platform is based on the latest Java ... into a specific piece of software for many key components of the suite. Much ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
Breaking Medicine Technology: